Forest’s Respiratory Pipeline: Can It Open The Revenue Airway?
This article was originally published in The Pink Sheet Daily
Executive Summary
At a June 20 analyst meeting, Forest Labs discussed the potential for its respiratory pipeline, including the recently launched Daliresp and the yet-to-be approved aclidinium, which has a July PDUFA date.